– USA, MA – 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, today announced the appointment of Tony Hunt to its Board of Directors, effective immediately.
“I am delighted to welcome Tony to the 908 Devices’ Board of Directors. Tony brings extensive market experience and valuable strategic insight into biopharmaceutical development and production. His significant track record of evaluating inorganic growth opportunities will also be an important addition to our Board,” said Board Chairman, Kevin Hrusovsky.
Kevin Knopp, CEO and co-founder added, “One of our key priorities is to create a comprehensive bioanalytics platform from biotherapeutic development through production. Tony’s wealth of knowledge and experience in downstream bioproduction workflows will be invaluable as we do so.”
About Tony J. Hunt
Mr. Hunt brings a deep understanding of the bioprocessing market, with more than 20 years of life sciences management experience. He joined Repligen in 2014 as COO and was promoted to his current role a year later. Mr. Hunt previously was President of Bioproduction at Life Technologies, which was acquired by Thermo Fisher Scientific in 2014. From 2000 to 2008, he was with Applied Biosystems as Senior Director of Pharma Programs where he launched the pharma analytics business that in 2008 became part of the bioproduction platform at Life Technologies.
“I am honored to join the 908 Devices Board at this exciting stage of the company’s journey,” said Tony Hunt. “The 908 Devices technology platform has tremendous potential to help researchers bring new therapeutics to market faster, and I look forward to partnering with the company’s leadership team to unlock this capability.”
About 908 Devices
908 Devices Inc. is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.
For more information: https://908devices.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
